Study: Invasive Pulmonary Aspergillosis Incidence in COVID-19
A new review, published in the Journal of Infectious Diseases, explores the incidence of COVID-19-associated invasive pulmonary aspergillosis.
A new review, published in the Journal of Infectious Diseases, explores the incidence of COVID-19-associated invasive pulmonary aspergillosis.
A new review, published in the Journal of Infectious Diseases, explores the incidence of COVID-19-associated invasive pulmonary aspergillosis.
Read MorePatients who had major sensitization to A. fumigatus were more likely to have severe asthma than controls (50% vs 15.6%).
Read MoreAspergillus fumigatus may increase the risk of developing bronchiectasis in COPD patients, according to researchers publishing in the International Journal of COPD.
Read MorePulmocide Ltd has raised $30.4 million to clinically develop its inhaled therapies to treat respiratory syncytial virus (RSV) and pulmonary aspergillosis.
Read MoreApproximately 50% of cystic fibrosis patients are also infected by the Aspergillus fungus, which is caused by an exposure to mold, according to new research.
Read MoreA researcher has developed a device for diagnosing pulmonary aspergillosis, a leading cause of death in acute leukemia and bone marrow transplant patients.
Read More